Investor Ideas Updates #Cannabis #Stock Directory
Following Legalization of Recreational Cannabis in California on New Year's Day
Point Roberts, WA, Delta BC – January 3, 2018 Investorideas.com,
a global news source and investor resource covering actively traded sectors
announces the release of its updated cannabis /hemp stock directory for January
2018 following news that recreational marijuana was legalized in California New
Year’s day.
Investorideas.com tracks cannabis and hemp publicly
traded companies on the TSX, TSX.V, CSE, OTC, NYSE, NASDAQ, ASX and global stock exchanges and makes ongoing
additions to its stock directories for its members. Free previews of all
directories are available to the public with full login access only accessible
to members
Marijuana/Hemp Stocks 2018
22nd
Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on
technology which allows it to increase or decrease the level of nicotine in
tobacco plants and the level of cannabinoids in cannabis plants through genetic
engineering and plant breeding. The Company’s primary mission is to reduce the
harm caused by smoking. 22nd Century currently owns or exclusively controls
more than 200 issued patents and more than 50 pending patent applications
around the world. The Company’s strong IP position led to a licensing agreement
with British American Tobacco (“BAT”), the world’s second largest tobacco
company.
3DX Industries Inc. (OTC: DDDX) is focused on the additive metal
manufacturing segment within the manufacturing industry. 3DX has the capability
of manufacturing a wide variety of products using its 3D metal printing system,
3D composite printing as well as more traditional methods of precision
manufacturing. 3DX offers additive and subtractive manufacturing options as
well as product design, engineering and assembly services to its
customers. Cannabis: Has completed the
development and design of a new and innovative product used for recovering
excess heat from high energy grow lights. The
part was designed specifically for the legalized cannabis markets including
medical marijuana using the company's 3D Metal printing -- Binder Additive
manufacturing process and is expected to be installed in select licensed
facilities for real world testing in the coming months.
ABATTIS BIOCEUTICALS (OTC:ATTBF; CSE:ATT) is a specialty biotechnology company with
capabilities through its wholly owned subsidiaries of cultivating, licensing
and marketing proprietary ingredients, bio-similar compounds, patented
equipment and consulting services to medicinal markets in North America. The
Company is positioned to capitalize on the fast growing trend toward marijuana
legalization in the United States and for medicinal use in Canada and
international jurisdictions, by supplying and partnering with companies to
employ its mass cultivation systems, extraction equipment/technology, and
strategic marketing support to licensed growers. The Company also has an
extensive pipeline of high-quality products and intellectual property for the
rapidly expanding botanical drug market. We follow strict standard operating
protocols, and adhere to the applicable laws of Canada and foreign
jurisdictions.
ABcann Global Corporation (TSX:ABCN.V) was one of the
first companies to obtain a production license under the Marijuana for Medical
Purposes Regulations, which it received on March 21, 2014. It obtained a sales
license on December 31, 2015. ABcann’s flagship facility, in Napanee, Ontario,
contains proprietary plant-growing technology, including
environmentally-controlled chambers capable of monitoring and regulating all
variables in the growing process. This approach and the systems in place allow
ABcann to produce organically grown and pesticide-free, high-yielding plants,
which, in turn, can generate high-quality products that are consistent from
batch to batch. ABcann is able to control environmental and nutrient demands,
tailor-made for a particular strain of cannabis, without the variation that is
typical when producing large quantities in less-controlled, larger rooms and
greenhouse-type structures. ABcann’s modular approach to systems technology
eliminates scale-up risk and allows ABcann to locate anywhere in the world and
maintain consistency and quality of product. ABcann is expanding capacity in
its current facility to approximately 30,000 sq ft and concurrently undertaking
expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing
opportunities in Germany, Australia and other jurisdictions as well as
exploring the development of multiple delivery vehicles.
Acology
Inc (OTC:ACOL) markets and sells the TSOS
Container™ (The Science of Storage).This container is the first-ever FDA
approved polypropylene air-tight, water-tight, smell-proof delivery and storage
container with a built-in grinder. It is manufactured from medical-grade No. 5
polypropylene resin, which is non-porous and non-leaching. These containers are
portable and affordable. he Medtainer™ allows patients to store, grind and pour
a variety of medications, including pills and all sizes and solidity, herbal
medications and teas and even coffee and spices! The Medtainer™ can be ordered
in with a certified child-resistant cap. Each Medtainer™ is water-proof and
smell proof. Caregivers who are responsible for ensuring their patients
medication regimens are universally pleased with the how easy and effective the
Medtainer™ grind medications. It is an excellent solution for patients with
dysphasia due to cognitive disorders or brain injuries, are in hospice or
palliative situations and for anyone who would rather not swallow whole pills.
The MedTainer™ was originally developed for geriatric and pediatric patients
who had difficulty swallowing pills or needed an effective alternative to
costly name-brand medications. The MedTainer™ has been sold and is being
successfully used throughout the United States, Canada, Mexico and South
America and Europe. Our association with the Medical Marijuana community was an
unexpected windfall that has given Acology, Inc. the necessary funding to
expand into the growing hospice and palliative care markets, and to help
countless patients who are living at home or in small home-like settings and
need help swallowing pills.
Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide
innovative healthcare products, holistic pain management solutions, and enhance
the footprint in the evolving legal cannabis business. Advantis acquires
ownership in developing companies that work within the nutraceutical and the
alternative health care industries; consulting with these organizations to
improve their product lines, expand their distribution channels through
internal partnership agreements, and heighten brand value.
Aequus Pharmaceuticals Inc. (TSX:AQS.V) is a growing specialty pharmaceutical
company focused on developing and commercializing high quality, differentiated
products. Aequus' development stage pipeline includes several products in neurology
and psychiatry with a goal of addressing the need for improved medication
adherence through enhanced delivery systems. Aequus intends to commercialize
its internal programs in Canada alongside its current portfolio of marketed
established medicines and will look to form strategic partnerships that would
maximize the reach of its product candidates worldwide. Aequus plans to build
on its Canadian commercial platform through the launch of additional products
that are either created internally or brought in through an acquisition or
license; remaining focused on highly specialized therapeutic areas. Cannabis: July 2017 - Aequus
Pharmaceuticals Inc., ("Aequus") (TSX VENTURE: AQS) (OTCQB: AQSZF), a
specialty life sciences company focused on providing patients with
differentiated and enhanced delivery systems for existing and approved drugs,
and Scientus Pharma Inc., ("Scientus"), a biopharmaceutical company
focused on R&D and product commercialization for extracts and formulations
related to medical cannabinoids and their derivatives, announced today that
they have signed a non-binding term sheet on a collaboration to develop, assess
clinical performance, and commercialize a cannabinoid containing transdermal
formulation designed and optimized to address both acute and chronic treatment
of Resistant Epilepsy, and certain other neurological disorders. Scientus will
be the supplier of specific cannabinoid extracts and will have an option to
co-fund the clinical development of this program. The parties expect to expand
the collaboration to additional product development programs in the future.
AeroGrow International, Inc. (OTC:AERO)
Headquartered in Boulder, Colorado, AeroGrow
International, Inc. is the leader in the rapidly growing indoor gardening
category. AeroGardens allow anyone to grow farmer's market fresh herbs, salad
greens, tomatoes, chili peppers, flowers and more, indoors, year-round, so
simply and easily that no green thumb is required. With an AeroGarden... you
can grow anything! In April 2013, AeroGrow entered into a strategic partnership
with Scotts Miracle-Gro to continue to expand the indoor gardening market.
AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is
focused on growing high quality crops such as romaine lettuce, spinach,
strawberries and high quality medical Marijuana. Affinor is committed to
becoming a pre-eminent grower, using exclusive vertical farming techniques.
Investorideas.com tracks companies in high profile
trading sectors and makes ongoing additions to its stock directories for each
sector. Listing for the stock directories include companies on the TSX,
OTC, NYSE, NASDAQ and global stock exchanges.
Investorideas.com global stock directories are part
of the membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com
is a meeting place for global investors, featuring news, stock directories,
video, podcasts, company profiles,
interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp
content now includes: http://cannabisstocknews.blogspot.com on
Blogger.com: the Investorideas.com news and stock directory pages, a cannabis
investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Services for Publicly traded and private companies: http://www.investorideas.com/Investors/Services.asp
Investorideas is Listed on The Canadian Securities Exchange
(CSE) Directory of Service Providers
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact each
company directly regarding content and press release questions. Disclosure is
posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
